• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国慢性炎症性疾病患者的流行病学数据与医疗状况:关于患病率、疾病组合及护理的真实世界证据

[Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].

作者信息

Riemekasten Gabriela, Schmelz Renate, Schäkel Knut, Thaci Diamant, Schreiber Stefan, Röcken Marit, Bartz Holger, Ploner Tina, Liao Ximing, Weber Valeria, Manz Karina C, Burkhardt Harald, Leipe Jan

机构信息

Klinik für Rheumatologie und klinische Immunologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland.

Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.

出版信息

Z Rheumatol. 2024 Sep;83(7):578-586. doi: 10.1007/s00393-023-01459-7. Epub 2023 Dec 9.

DOI:10.1007/s00393-023-01459-7
PMID:38071271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11442525/
Abstract

BACKGROUND

Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical similarities. The resulting utilization of heathcare structures has not yet been investigated across disciplines but is of potential importance for optimizing the treatment of patients with IMID.

AIM OF THE WORK

Analysis of epidemiological data including utilization of care services in patients with selected IMIDs: psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis, ulcerative colitis, Crohn's disease and connective tissue disease.

MATERIAL AND METHODS

In a retrospective cross-sectional analysis based on health insurances accounting data with a sample of approximately 4 million insured persons, the prevalence of the abovementioned IMID and the frequency of IMID combinations were analyzed based on documented diagnoses (ICD-10 GM). The frequency of hospitalizations and utilization of outpatient physician contacts was recorded in predefined specialist disciplines (general medicine, dermatology, gastroenterology, rheumatology) and compared with an age-adjusted and gender-adjusted reference population.

RESULTS

A total of 188,440 patients had at least 1 of the IMID diagnoses analyzed (4.7%), with an age peak of 61-70 years. The highest prevalence was observed for psoriasis (1.85%), followed by rheumatoid arthritis (1.38%). Combinations with at least one other IMID were relatively common (29%), with this being most common in patients with psoriatic arthritis (82.9%, of which 68.2% had psoriasis), followed by ankylosing spondylitis (27.5%) and Crohn's disease (21.6%). Compared to the reference population, patients with IMID were hospitalized more often and more frequently utilized the outpatient disciplines.

DISCUSSION

The study results describe that IMIDs occur in combination and that the patients make comparatively more use of care structures of different disciplines. A multidisciplinary approach could increase the efficiency of care; an evaluation is still pending.

摘要

背景

慢性炎症性疾病(免疫介导的炎症性疾病,IMID)由于临床相似性可能会重叠或同时发生。目前尚未跨学科研究由此导致的医疗保健结构利用情况,但这对于优化IMID患者的治疗具有潜在重要性。

工作目的

分析包括选定IMID患者的护理服务利用情况在内的流行病学数据,这些IMID包括银屑病、银屑病关节炎(PsA)、类风湿关节炎(RA)、强直性脊柱炎、溃疡性结肠炎、克罗恩病和结缔组织病。

材料与方法

在一项基于医疗保险核算数据的回顾性横断面分析中,以约400万参保人员为样本,根据记录的诊断(ICD-10 GM)分析上述IMID的患病率和IMID组合的频率。记录在预定义专科领域(普通内科、皮肤科、胃肠病学、风湿病学)的住院频率和门诊医生就诊利用情况,并与年龄和性别调整后的参考人群进行比较。

结果

共有188440名患者至少有1项所分析的IMID诊断(4.7%),年龄峰值为61至70岁。银屑病的患病率最高(1.85%),其次是类风湿关节炎(1.38%)。与至少一种其他IMID的组合相对常见(29%),在银屑病关节炎患者中最为常见(82.9%,其中68.2%患有银屑病),其次是强直性脊柱炎(27.5%)和克罗恩病(21.6%)。与参考人群相比,IMID患者住院更频繁,门诊专科就诊也更频繁。

讨论

研究结果表明IMID会合并发生,且患者相对更多地利用不同学科的护理结构。多学科方法可能会提高护理效率;仍有待评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/6179b8055cda/393_2023_1459_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/59bfe67a4cf9/393_2023_1459_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/8960a5ad243c/393_2023_1459_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/6179b8055cda/393_2023_1459_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/59bfe67a4cf9/393_2023_1459_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/8960a5ad243c/393_2023_1459_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f41/11442525/6179b8055cda/393_2023_1459_Fig3_HTML.jpg

相似文献

1
[Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].德国慢性炎症性疾病患者的流行病学数据与医疗状况:关于患病率、疾病组合及护理的真实世界证据
Z Rheumatol. 2024 Sep;83(7):578-586. doi: 10.1007/s00393-023-01459-7. Epub 2023 Dec 9.
2
[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].[德国的免疫介导性炎症疾病:合并症与药物治疗的横断面分析]
Z Rheumatol. 2024 Apr;83(3):200-209. doi: 10.1007/s00393-022-01306-1. Epub 2023 Jan 4.
3
[Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain].[西班牙十种免疫介导性炎症疾病(IMID)的患病率]
Rev Esp Salud Publica. 2019 Mar 25;93:e201903013.
4
Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.发展为其他免疫介导表现的风险:一项回顾性匹配队列研究。
Adv Ther. 2019 Jul;36(7):1672-1683. doi: 10.1007/s12325-019-00964-z. Epub 2019 May 17.
5
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.与对照组相比,免疫介导的炎症性疾病患者的新冠病毒肺炎住院、重症监护病房停留、通气情况及死亡情况
J Rheumatol. 2022 May;49(5):523-530. doi: 10.3899/jrheum.211012. Epub 2022 Feb 1.
6
Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.基于倾向性评分匹配的系统性免疫介导的炎症性疾病与年龄相关性黄斑变性风险分析。
Ophthalmol Retina. 2024 Aug;8(8):778-785. doi: 10.1016/j.oret.2024.01.026. Epub 2024 Feb 4.
7
Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.德国类风湿关节炎、银屑病关节炎和银屑病患者的流行病学和治疗:一项真实世界证据研究。
Adv Ther. 2021 Jan;38(1):366-385. doi: 10.1007/s12325-020-01522-8. Epub 2020 Oct 30.
8
Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.免疫介导的炎症性疾病患者的共病情况:利用2001 - 2002年美国医疗保健理赔数据进行的探索
Curr Med Res Opin. 2006 May;22(5):989-1000. doi: 10.1185/030079906X104641.
9
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.1997 年至 2018 年英国巩膜炎的流行病学:基于人群的 1100 万患者分析及巩膜炎与感染性和免疫介导性炎症性疾病的相关性。
Arthritis Rheumatol. 2021 Jul;73(7):1267-1276. doi: 10.1002/art.41709. Epub 2021 Jun 6.
10
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.患者支持计划对克罗恩病、溃疡性结肠炎、类风湿性关节炎、银屑病、银屑病关节炎和强直性脊柱炎患者阿达木单抗依从性和直接医疗费用的影响。
J Manag Care Spec Pharm. 2017 Aug;23(8):859-867. doi: 10.18553/jmcp.2017.16272. Epub 2017 Mar 15.

本文引用的文献

1
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.欧洲克罗恩病和结肠炎组织(ECCO)炎症性肠病肠外表现指南
J Crohns Colitis. 2024 Jan 27;18(1):1-37. doi: 10.1093/ecco-jcc/jjad108.
2
High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex.患有银屑病关节炎患者的高药物负担和共病负担:按年龄和性别分层的索赔数据分析。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2022-002960.
3
[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].
[德国的免疫介导性炎症疾病:合并症与药物治疗的横断面分析]
Z Rheumatol. 2024 Apr;83(3):200-209. doi: 10.1007/s00393-022-01306-1. Epub 2023 Jan 4.
4
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version].[德国炎症性风湿性疾病患病率的系统评价。德文版]
Z Rheumatol. 2023 Nov;82(9):727-738. doi: 10.1007/s00393-022-01305-2. Epub 2023 Jan 2.
5
Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.银屑病关节炎伴发炎症性肠病或葡萄膜炎的管理:更新综述为 2021 年 GRAPPA 治疗推荐提供信息。
J Rheumatol. 2023 Mar;50(3):438-450. doi: 10.3899/jrheum.220317. Epub 2022 Dec 1.
6
Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross-sectional patient-reported survey data.使用不同算法在德国索赔数据中识别类风湿性关节炎:通过横断面患者报告调查数据进行验证
Pharmacoepidemiol Drug Saf. 2023 May;32(5):517-525. doi: 10.1002/pds.5562. Epub 2022 Dec 8.
7
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.银屑病关节炎研究和评估组(GRAPPA):2021 年银屑病关节炎更新的治疗建议。
Nat Rev Rheumatol. 2022 Aug;18(8):465-479. doi: 10.1038/s41584-022-00798-0. Epub 2022 Jun 27.
8
Epidemiology of skin diseases in Germany: systematic review of the current state of research - part 2: non-infectious skin diseases.德国皮肤病流行病学:当前研究现状的系统评价-第 2 部分:非传染性皮肤病。
J Dtsch Dermatol Ges. 2022 Apr;20(4):445-455. doi: 10.1111/ddg.14727. Epub 2022 Apr 13.
9
[Is the prevalence of rheumatoid arthritis truly on the rise?].类风湿关节炎的患病率真的在上升吗?
Z Rheumatol. 2022 May;81(4):323-327. doi: 10.1007/s00393-022-01192-7. Epub 2022 Mar 31.
10
Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis.炎症性肠病影响共存的免疫介导的炎症性疾病的表型和疾病进程:系统评价和荟萃分析。
Inflamm Bowel Dis. 2022 Nov 2;28(11):1756-1765. doi: 10.1093/ibd/izac003.